Salvage therapy versus upfront autologous stem cell transplantation in multiple myeloma patients with progressive disease after first-line induction therapy

Joanna Blocka,Thomas Hielscher,Carsten Mueller-Tidow,Hartmut Goldschmidt,Jens Hillengass

Salvage therapy versus upfront autologous stem cell transplantation in multiple myeloma patients with progressive disease after first-line induction therapy

2019

Joanna Blocka
Thomas Hielscher
Carsten Mueller-Tidow
Hartmut Goldschmidt
Jens Hillengass

AbstractIt is a matter of debate whether myeloma patients with progressive disease (PD) after induction should receive salvage therapy or proceed directly to autologous stem cell transplantation. W...

Keywords:

Internal medicine
Diabetes mellitus
Oncology
Autologous stem-cell transplantation
Medicine
Progressive disease
Immunology
Salvage therapy
Multiple myeloma
first line
induction therapy

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations